Trillium Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.3M | Buy |
81,412
+2,757
| +4% | +$386K | 0.38% | 75 |
|
|
2025
Q4 | $10.1M | Sell |
78,655
-19,940
| -20% | -$2.42M | 0.31% | 80 |
|
|
2025
Q3 | $10.9M | Sell |
98,595
-3,921
| -4% | -$446K | 0.29% | 85 |
|
|
2025
Q2 | $11.4M | Sell |
102,516
-2,640
| -3% | -$281K | 0.31% | 85 |
|
|
2025
Q1 | $11.8M | Sell |
105,156
-40,297
| -28% | -$4.16M | 0.34% | 86 |
|
|
2024
Q4 | $13.4M | Sell |
145,453
-10,464
| -7% | -$942K | 0.35% | 84 |
|
|
2024
Q3 | $13.1M | Sell |
155,917
-5,311
| -3% | -$405K | 0.32% | 86 |
|
|
2024
Q2 | $11.1M | Sell |
161,228
-2,901
| -2% | -$194K | 0.28% | 88 |
|
|
2024
Q1 | $12M | Buy |
164,129
+32,792
| +25% | +$2.52M | 0.31% | 89 |
|
|
2023
Q4 | $10.6M | Sell |
131,337
-364
| -0.3% | -$28.3K | 0.29% | 90 |
|
|
2023
Q3 | $9.87M | Sell |
131,701
-1,435
| -1% | -$110K | 0.3% | 88 |
|
|
2023
Q2 | $10.3M | Buy |
133,136
+37,396
| +39% | +$2.98M | 0.29% | 95 |
|
|
2023
Q1 | $7.87M | Buy |
95,740
+13
| +0% | +$1.08K | 0.23% | 94 |
|
|
2022
Q4 | $8.22M | Sell |
95,727
-4,760
| -5% | -$377K | 0.25% | 98 |
|
|
2022
Q3 | $6.2M | Sell |
100,487
-1,359
| -1% | -$85.7K | 0.2% | 109 |
|
|
2022
Q2 | $6.29M | Sell |
101,846
-5,017
| -5% | -$311K | 0.19% | 108 |
|
|
2022
Q1 | $6.35M | Sell |
106,863
-98,480
| -48% | -$6.3M | 0.17% | 115 |
|
|
2021
Q4 | $14.9M | Buy |
205,343
+2,668
| +1% | +$184K | 0.35% | 87 |
|
|
2021
Q3 | $14.2M | Buy |
202,675
+6,153
| +3% | +$432K | 0.37% | 85 |
|
|
2021
Q2 | $13.5M | Buy |
196,522
+407
| +0.2% | +$27.2K | 0.37% | 85 |
|
|
2021
Q1 | $12.7M | Buy |
196,115
+483
| +0.2% | +$31.1K | 0.4% | 82 |
|
|
2020
Q4 | $11.4M | Sell |
195,632
-31,327
| -14% | -$1.89M | 0.41% | 80 |
|
|
2020
Q3 | $14.3M | Sell |
226,959
-1,755
| -0.8% | -$122K | 0.6% | 61 |
|
|
2020
Q2 | $17.6M | Sell |
228,714
-21,064
| -8% | -$1.61M | 0.75% | 48 |
|
|
2020
Q1 | $18.7M | Buy |
249,778
+10,444
| +4% | +$722K | 0.98% | 31 |
|
|
2019
Q4 | $15.6M | Sell |
239,334
-30,800
| -11% | -$2.01M | 0.69% | 48 |
|
|
2019
Q3 | $17.1M | Buy |
270,134
+112,436
| +71% | +$7.35M | 0.8% | 38 |
|
|
2019
Q2 | $10.7M | Sell |
157,698
-16,235
| -9% | -$1.07M | 0.51% | 71 |
|
|
2019
Q1 | $11.3M | Buy |
173,933
+195
| +0.1% | +$13K | 0.57% | 65 |
|
|
2018
Q4 | $10.9M | Sell |
173,738
-1,910
| -1% | -$134K | 0.63% | 61 |
|
|
2018
Q3 | $13.6M | Buy |
175,648
+28,213
| +19% | +$2.13M | 0.68% | 54 |
|
|
2018
Q2 | $10.4M | Buy |
147,435
+73,759
| +100% | +$5.21M | 0.56% | 71 |
|
|
2018
Q1 | $5.55M | Buy |
73,676
+12,708
| +21% | +$1.01M | 0.31% | 107 |
|
|
2017
Q4 | $4.37M | Sell |
60,968
-709
| -1% | -$53.8K | 0.24% | 117 |
|
|
2017
Q3 | $5M | Sell |
61,677
-1,107
| -2% | -$84.6K | 0.29% | 109 |
|
|
2017
Q2 | $4.44M | Buy |
62,784
+13,300
| +27% | +$885K | 0.27% | 116 |
|
|
2017
Q1 | $3.36M | Sell |
49,484
-46,499
| -48% | -$3.27M | 0.21% | 125 |
|
|
2016
Q4 | $6.87M | Sell |
95,983
-81,663
| -46% | -$6.07M | 0.45% | 85 |
|
|
2016
Q3 | $14.1M | Sell |
177,646
-75,142
| -30% | -$6.1M | 0.9% | 37 |
|
|
2016
Q2 | $21.1M | Sell |
252,788
-6,207
| -2% | -$551K | 1.39% | 8 |
|
|
2016
Q1 | $23.8M | Buy |
258,995
+46,258
| +22% | +$4.17M | 1.58% | 5 |
|
|
2015
Q4 | $21.5M | Sell |
212,737
-14,275
| -6% | -$1.49M | 1.45% | 12 |
|
|
2015
Q3 | $22.3M | Buy |
227,012
+1,563
| +0.7% | +$174K | 1.56% | 10 |
|
|
2015
Q2 | $26.4M | Buy |
225,449
+1,743
| +0.8% | +$190K | 1.69% | 7 |
|
|
2015
Q1 | $22M | Sell |
223,706
-59,554
| -21% | -$6.05M | 1.42% | 7 |
|
|
2014
Q4 | $26.7M | Buy |
283,260
+22,144
| +8% | +$2.29M | 1.81% | 5 |
|
|
2014
Q3 | $27.8M | Buy |
261,116
+17,483
| +7% | +$1.71M | 2.4% | 2 |
|
|
2014
Q2 | $20.2M | Buy |
243,633
+17,661
| +8% | +$1.37M | 1.73% | 8 |
|
|
2014
Q1 | $16M | Buy |
225,972
+8,122
| +4% | +$637K | 1.51% | 13 |
|
|
2013
Q4 | $16.4M | Buy |
217,850
+41,963
| +24% | +$2.92M | 1.61% | 6 |
|
|
2013
Q3 | $11.1M | Buy |
+175,887
| New | +$10.5M | 1.23% | 23 |
|
Other funds holding GILD
VCM
VPM
Trillium Asset Management's GILD Position: Q1 2026 in Review
Trillium Asset Management increased its Gilead Sciences (GILD) stake by 3.5% in Q1 2026, buying an estimated $386K and bringing the position to 81,412 shares worth $11.3M. The position accounts for 0.38% of the portfolio, ranked #75.
Trillium Asset Management first reported a position in GILD in Q3 2013 and has held it in 51 quarters since. The position peaked at $27.8M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Trillium Asset Management held 81,412 shares of Gilead Sciences worth $11.3M as of Q1 2026.
- Trillium Asset Management bought 2,757 Gilead Sciences shares in Q1 2026, an estimated $386K.
- Gilead Sciences made up 0.38% of Trillium Asset Management's portfolio in Q1 2026, its #75 holding.
- Trillium Asset Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 51 quarters since.
- Trillium Asset Management's Gilead Sciences position peaked at $27.8M in Q3 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Trillium Asset Management's 13F filing for Q1 2026, filed 11 May 2026.